13F filer · CIK 1422848 ↗
Capital Research Global Investors
You are looking at Q2 2021. See the latest, Q2 2026 →
Reported value
$429.52B
+5.1% on the quarter before
Positions
436
36 new · 25 sold out
Top 10
28.8%
of the value
Est. gain
+$28.95B
on stocks held all quarter
Est. return
+7.6%
on those stocks since Q1 2021
Positions as of Jun 30, 2021, from Capital Research Global Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 47% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2021. Striped tiles are options.
Largest buys
Since Q1 2021, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Shopify Inc~$1.70BAdded · 0.0% → 0.4%+1,165,602 shares
- Pepsico Inc~$975.4MAdded · 0.3% → 0.6%+6,583,081 shares
- Futu Hldgs Ltd~$653.8MAdded · 0.1% → 0.2%+3,650,857 shares
- Ferrari N V~$604.1MNew · 0.0% → 0.1%+2,928,136 shares
- MercadoLibre~$597.9MAdded · 1.2% → 1.4%+383,791 shares
- Netflix~$550.2MAdded · 3.6% → 3.6%+1,041,713 shares
- Tfi Intl Inc~$543.1MNew · 0.0% → 0.1%+5,955,919 shares
- Meta~$534.7MAdded · 2.7% → 3.2%+1,537,808 shares
- Micron~$462.6MAdded · 0.3% → 0.3%+5,443,651 shares
- General Electric Co~$450.5MAdded · 0.6% → 0.7%+33,472,062 shares
Largest sells
Since Q1 2021, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Broadcom~$1.38BCut · 3.4% → 3.0%−2,888,587 shares
- Microsoft~$1.28BCut · 5.7% → 6.0%−4,710,283 shares
- Constellation Brands Inc~$1.03BCut · 0.3% → 0.1%−4,413,352 shares
- Eog Res Inc~$913.0MCut · 1.3% → 1.2%−10,941,541 shares
- Amgen Inc~$806.3MCut · 2.0% → 1.7%−3,307,947 shares
- Philip Morris Intl Inc~$658.4MCut · 1.4% → 1.3%−6,642,979 shares
- Mastercard~$629.4MCut · 1.7% → 1.5%−1,723,851 shares
- Intel~$576.6MSold out · 0.1% → 0.0%−9,009,004 shares
- Canadian Nat Res Ltd~$564.1MCut · 1.1% → 1.1%−15,538,465 shares
- Conocophillips~$546.4MCut · 0.3% → 0.2%−8,971,973 shares
Holdings
As of Jun 30, 2021. Changes are in shares against Mar 31, 2021, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares −4.7% · price +14.9% | 6.0% | $25.62B | +$3.32B | ||||||||
| NetflixCOM · shares +3.7% · price +1.3% | 3.6% | $15.62B | +$187.1M | ||||||||
| MetaCL A · shares +4.1% · price +18.1% | 3.2% | $13.68B | +$2.01B | ||||||||
| BroadcomCOM · shares −9.7% · price +2.8% | 3.0% | $12.85B | +$355.1M | ||||||||
| AmazonCOM · shares +0.8% · price +11.2% | 3.0% | $12.84B | +$1.28B | ||||||||
| Abbott LabsCOM · shares +0.03% · price −3.3% | 2.3% | $9.95B | −$335.4M | ||||||||
| AlphabetCAP STK CL A · shares −4.2% · price +18.4% | 2.2% | $9.36B | +$1.45B | ||||||||
| Gilead Sciences IncCOM · shares −4.8% · price +6.5% | 1.9% | $8.03B | +$493.5M | ||||||||
| AlphabetCAP STK CL C · shares −0.4% · price +21.2% | 1.8% | $7.90B | +$1.38B | ||||||||
| Comcast Corp NewCL A · shares +0.6% · price +5.4% | 1.8% | $7.74B | +$392.3M | ||||||||
| Unitedhealth Group IncCOM · shares −4.8% · price +7.6% | 1.7% | $7.26B | +$514.5M | ||||||||
| Amgen IncCOM · shares −10% · price −2.0% | 1.7% | $7.14B | −$148.3M | ||||||||
| Jpmorgan Chase & CoCOM · shares −6.9% · price +2.2% | 1.5% | $6.57B | +$139.9M | ||||||||
| MastercardCL A · shares −8.9% · price +2.5% | 1.5% | $6.46B | +$160.1M | ||||||||
| Vale S ASPONSORED ADS · shares −0.8% · price +31.2% | 1.4% | $6.10B | +$1.45B | ||||||||
| MercadoLibreCOM · shares +11% · price +5.8% | 1.4% | $5.82B | +$287.5M | ||||||||
| General Mtrs CoCOM · shares −4.8% · price +3.0% | 1.3% | $5.70B | +$164.9M | ||||||||
| Philip Morris Intl IncCOM · shares −10% · price +11.7% | 1.3% | $5.63B | +$588.6M | ||||||||
| Home Depot IncCOM · shares −6.3% · price +4.5% | 1.2% | $5.09B | +$217.6M | ||||||||
| Eog Res IncCOM · shares −15% · price +15.0% | 1.2% | $5.03B | +$658.1M | ||||||||
| Canadian Nat Res LtdCOM · shares −11% · price +17.4% | 1.1% | $4.58B | +$680.2M | ||||||||
| Thermo Fisher Scientific IncCOM · shares +2.3% · price +10.5% | 1.1% | $4.57B | +$425.9M | ||||||||
| Csx CorpCOM · shares −6.5% · price −0.2% | 1.1% | $4.55B | −$8.6M | ||||||||
| Raytheon Technologies CorpCOM · shares −2.9% · price +10.4% | 0.96% | $4.12B | +$388.7M | ||||||||
| Linde PlcSHS · shares −6.6% · price +3.2% | 0.89% | $3.83B | +$118.3M | ||||||||
| Total · 436 positions | 100% | $429.52B | +$28.95B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2021 to Q2 2021: 400 stocks held throughout, up $28.95B (+7.6%).
- Microsoft+$3.32B+15%
- Meta+$2.01B+18%
- Vale S A+$1.45B+31%
- Alphabet+$1.45B+18%
- Alphabet+$1.38B+21%
- Amgen Inc−$148.3M−2%
- Allakos Inc−$168.7M−26%
- Teva Pharmaceutical Inds Ltd−$201.1M−14%
- Airbnb−$203.0M−19%
- Abbott Labs−$335.4M−3%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 2 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $716.87B+11% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $644.56B+19% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $541.73B+2% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $532.97B+7% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $499.46B+9% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $459.90B−5% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $486.38B+1% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $481.14B+6% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $455.74B+3% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $441.98B+9% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $406.47B+12% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $363.16B−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $373.18B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $350.40B+6% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $330.88B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $304.37B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $321.05B−21% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $405.10B−11% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $452.67B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $428.65B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $429.52B+5% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $408.71B+6% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $385.30B+16% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $333.11B+5% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $316.13B+24% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $254.90B−24% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $333.48B+9% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $304.85B−3% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $314.99B−0% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $315.45B+10% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $287.02B−17% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $344.02B−6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $366.12B+4% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $351.43B+3% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $340.76B+3% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $331.24B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $319.49B+1% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $317.04B+3% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $308.47B+2% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $302.53B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $292.47B+1% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $290.06B | SEC ↗ |